Dr. Amanda Olson
Claim this profileM D Anderson Cancer Center
Area of expertise
Cancer
Amanda Olson has run 5 trials for Cancer. Some of their research focus areas include:
Heart Failure
Amanda Olson has run 2 trials for Heart Failure.
Affiliated Hospitals
M D Anderson Cancer Center
MD Anderson Cancer Center (MDACC)
Clinical Trials Amanda Olson is currently running
Adoptive Immunotherapy
for Viral Infections
This Phase I-II dose-finding trial to determine the optimal dose of intravenous (IV) injection dose of donor-derived cytotoxic T lymphocytes (CTLs) specific for CMV, EBV, BKV and Adenovirus. A maximum of 36 patients will be treated in up to 18 cohorts each of size 2, with the first cohort treated at the lowest dose level 1, all successive doses chosen by the EffTox method, and no untried dose level skipped when escalating. The scientific goal of the trial is to determine an optimal IV-CTL cell dose level among the three doses 1.0x107cells/m2, 2 x107cells/m2 and 5x107cells/m2., hereafter dose levels 1, 2, 3. Dose-finding will be done using the sequentially adaptive EffTox trade-off-based design of Thall et al.
Recruiting
1 award
Phase 1 & 2
5 criteria
Cytotoxic T Lymphocytes
for Virus-Related Cancer
This phase II trial studies how well donor cytotoxic T lymphocytes work in treating patients with malignancies with BK and/or JC virus. Cytotoxic T lymphocytes are made from donated blood cells that are grown in the laboratory and are designed to kill viruses that can cause infections in transplant patients and may be an effective treatment in patients with malignancies with BK and/or JC virus.
Recruiting
1 award
Phase 2
7 criteria
More about Amanda Olson
Clinical Trial Related
5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Amanda Olson has experience with
- Mesenchymal Stem Cell Transplantation
- Allogeneic BK-specific Cytotoxic T-lymphocytes
- Allogeneic Natural Killer Cell Line NK-92
- CMV/AdV /EBV/BKV Specific T Cells
- Fludarabine
- Cyclophosphamide
Breakdown of trials Amanda Olson has run
Cancer
Heart Failure
Blood Cancers
Uraemic Cardiomyopathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amanda Olson specialize in?
Amanda Olson focuses on Cancer and Heart Failure. In particular, much of their work with Cancer has involved -5/5q- positive patients, or patients who are abn(3q) positive.
Is Amanda Olson currently recruiting for clinical trials?
Yes, Amanda Olson is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Amanda Olson has studied deeply?
Yes, Amanda Olson has studied treatments such as Mesenchymal Stem Cell Transplantation, Allogeneic BK-specific Cytotoxic T-lymphocytes, Allogeneic Natural Killer Cell Line NK-92.
What is the best way to schedule an appointment with Amanda Olson?
Apply for one of the trials that Amanda Olson is conducting.
What is the office address of Amanda Olson?
The office of Amanda Olson is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.